FAQ :: XORTX Therapeutics Inc. (XRTX)

What is XORTX Therapeutics Inc.'s stock symbol?: Our stock is traded on the TSXV under the symbol XRTX and on the Nasdaq under the symbol XRTX.
When was XORTX Therapeutics Inc. incorporated?: We were incorporated under the laws of Alberta, Canada on August 24, 2012, under the name ReVasCor Inc. and were continued under the Canada Business Corporations Act on February 27, 2013, under the name of XORTX Pharma Corp. Upon completion of a reverse take-over transaction on January 10, 2018, with APAC Resources Inc., a company incorporated under the laws of British Columbia, we changed our name to “XORTX Therapeutics Inc.” and XORTX Pharma Corp. became a wholly-owned subsidiary.
When did XORTX Therapeutics Inc. become a public company?: XORTX was listed on the Canadian Securities Exchange on January 9, 2018.
Where is XORTX Therapeutics Inc. located?: 3710 – 33rd Street NW
Calgary, Alberta T2L 2M1
Canada
When is XORTX Therapeutics Inc.'s fiscal year end?: December 31st
Who is XORTX Therapeutics Inc.'s transfer agent?: TSX Trust Company
Investor Services
100 Adelaide Street West
Suite 301
Toronto, ON M5H 4H1
Canada
T: 416-342-1091
tmxeinvestorservices@tmx.com